BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28448892)

  • 1. Role of procalcitonin in infected diabetic foot ulcer.
    Park JH; Suh DH; Kim HJ; Lee YI; Kwak IH; Choi GW
    Diabetes Res Clin Pract; 2017 Jun; 128():51-57. PubMed ID: 28448892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer?
    Zakariah NA; Bajuri MY; Hassan R; Ismail Z; Md Mansor M; Othman H; Nasuruddin DN
    Malays J Pathol; 2020 Apr; 42(1):77-84. PubMed ID: 32342934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.
    Umapathy D; Dornadula S; Rajagopalan A; Murthy N; Mariappanadar V; Kesavan R; Kunka Mohanram R
    J Vasc Surg; 2018 Apr; 67(4):1283-1291.e2. PubMed ID: 28736121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Procalcitonin (PCT) - Is there a Role as an Early Biomarker in Infected Diabetic Foot Ulcer (IDFU) Patients?
    Omar J; Ahmad NS; Che-Soh N; Wan-Azman WN; Yaacob NM; Abdul-Ghani NS; Abdullah MR
    Malays Orthop J; 2023 Jul; 17(2):62-69. PubMed ID: 37583519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?
    Jonaidi Jafari N; Safaee Firouzabadi M; Izadi M; Safaee Firouzabadi MS; Saburi A
    Int J Endocrinol Metab; 2014 Jan; 12(1):e13376. PubMed ID: 24696696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Evaluation of the Diagnostic Value of Procalcitonin and hsCRP for the Presence of Mild-to-Moderate Diabetic Foot Infections.
    Todorova AS; Dimova RB; Chakarova NY; Serdarova MS; Grozeva GG; Georgiev GK; Tankova TI
    Int J Low Extrem Wounds; 2023 Jun; 22(2):353-359. PubMed ID: 33909506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.
    Jeandrot A; Richard JL; Combescure C; Jourdan N; Finge S; Rodier M; Corbeau P; Sotto A; Lavigne JP
    Diabetologia; 2008 Feb; 51(2):347-52. PubMed ID: 17934713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Serum Procalcitonin, Interleukin-6, and Fibrinogen Levels in Differential Diagnosis of Diabetic Foot Ulcer Infection.
    Korkmaz P; Koçak H; Onbaşı K; Biçici P; Özmen A; Uyar C; Özatağ DM
    J Diabetes Res; 2018; 2018():7104352. PubMed ID: 29675434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of procalcitonin as a marker of diabetic foot ulcer infection.
    Massara M; De Caridi G; Serra R; Barillà D; Cutrupi A; Volpe A; Cutrupi F; Alberti A; Volpe P
    Int Wound J; 2017 Feb; 14(1):31-34. PubMed ID: 26511007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of procalcitonin, erythrocyte sedimentation rate (ESR), quantitative C-reactive protein (CRP) and clinical findings associated with osteomyelitis in patients with diabetic foot.
    Soleimani Z; Amighi F; Vakili Z; Momen-Heravi M; Moravveji SA
    Hum Antibodies; 2021; 29(2):115-121. PubMed ID: 33749641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).
    Ingram JR; Cawley S; Coulman E; Gregory C; Thomas-Jones E; Pickles T; Cannings-John R; Francis NA; Harding K; Hood K; Piguet V
    Diabet Med; 2018 Feb; 35(2):255-261. PubMed ID: 28734103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study.
    Mutluoğlu M; Uzun G; İpcioğlu OM; Sildiroglu O; Özcan Ö; Turhan V; Mutlu H; Yildiz S
    Diabetes Res Clin Pract; 2011 Oct; 94(1):53-6. PubMed ID: 21658786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?
    Ozer Balin S; Sagmak Tartar A; Uğur K; Kilinç F; Telo S; Bal A; Balin M; Akbulut A
    Int Wound J; 2019 Jun; 16(3):659-664. PubMed ID: 30767386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis.
    Sharma H; Sharma S; Krishnan A; Yuan D; Vangaveti VN; Malabu UH; Haleagrahara N
    PLoS One; 2022; 17(4):e0267412. PubMed ID: 35476639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study.
    Altay FA; Sencan İ; Şentürk GÇ; Altay M; Güvenman S; Ünverdi S; Açıkgöz ZC
    J Diabetes Complications; 2012; 26(3):214-8. PubMed ID: 22521320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].
    Dong Z; Jianxin Z; Haraguchi G; Arai H; Mitaka C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):478-9. PubMed ID: 25163104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
    Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study.
    Hadavand F; Amouzegar A; Amid H
    Arch Acad Emerg Med; 2019; 7(1):37. PubMed ID: 31555767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.